Fenofibrate Tablet
Product Images NDC 0904-7539

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 0904-7539). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

160mg Carton Label (3f4e5db8 5bfb 4b24 8465 9757cbaad2be 00)

160mg Carton Label (3f4e5db8 5bfb 4b24 8465 9757cbaad2be 00)
This text provides information on Fenofibrate Tablets, USP, with each film-coated tablet containing Fenofibrate, USP 160 mg. The product is intended for institutional use only and should be stored at controlled room temperature. It also includes details on dosage, precautions, and warnings. The drug is from NDC #70756-215, manufactured by Festar Pharma LLC, and distributed by Major Pharmaceuticals in Indianapolis, USA. It is available in a unit dose package of 30 tablets.*
FDA Label Image

Fenofibrate Structural Formula (95807ea5 4d6b 4a8a 90e1 624ab1e870a6 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.